GenotypingHLA-B*5801for Allopurinol-Induced Severe Cutaneous Adverse Reactions: An Accurate and Prompt Method

Clinical and Translational Science - United Kingdom
doi 10.1111/cts.12365
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Severe Cutaneous Adverse Reactions

2013English

Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2015English

Pharmacogenomics of Severe Cutaneous Adverse Reactions and Drug-Induced Liver Injury

Journal of Human Genetics
Genetics
2013English

Drug-Induced Severe Cutaneous Adverse Reactions (SCARs): Determine the Cause and Prevention

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Cyclosporine - An Eye Opener in Severe Cutaneous Adverse Drug Reactions

IP Indian Journal of Clinical and Experimental Dermatology
2018English

Severe Adverse Reactions Prompt Call for Trial Design Changes

BMJ
2006English

Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions

JAMA Dermatology
DermatologyMedicine
2018English

Cutaneous Adverse Drug Reactions Induced by Amlodipine.

Cardiologia Croatica
Cardiovascular MedicineCardiology
2014English

Mechanisms of Severe Cutaneous Adverse Reactions and a New Treatment Strategy

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy